← Eichor
Condition: Gastroesophageal Cancer Gc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Gastroesophageal Cancer Gc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC
Phase 3 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT04342910A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gast
Phase 2 · 70 location(s) · AstraZeneca · NCT07069712Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens
Phase 1/Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06572319BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer
Phase 1 · 1 location(s) · Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. · NCT06773312BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
Phase 2 · 1 location(s) · Barbara Malene Fischer · NCT07629609Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)
Phase 1 · 1 location(s) · University of California, Irvine · NCT05733689Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Phase 1/Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06650332Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Phase 3 · 15 location(s) · SOFIE · NCT07217704Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
Phase 2 · 1 location(s) · Peking University · NCT06023758Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer
NA · 1 location(s) · Qilu Hospital of Shandong University · NCT07635836A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric
Phase 2 · 1 location(s) · Beijing Friendship Hospital · NCT07315854A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Phase 1 · 10 location(s) · Epkin · NCT06789172XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC
Phase 1/Phase 2 · 2 location(s) · West China Hospital · NCT06742411A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Posit
Phase 3 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT07518147SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure
Phase 2 · 1 location(s) · Jingdong Zhang · NCT07311408Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Phase 1/Phase 2 · 1 location(s) · BigHat Biosciences, Inc. · NCT07529808Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer
Phase N/A · 1 location(s) · Karolinska Institutet · NCT06687291A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Phase 1 · 48 location(s) · Seagen, a wholly owned subsidiary of Pfizer · NCT06131840A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alon
Phase 1/Phase 2 · 67 location(s) · BioNTech SE · NCT07070232A Phase 1 Study of the Safety and Tolerability of CTX-10726
Phase 1 · 6 location(s) · Compass Therapeutics · NCT07419841LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gast
Phase 3 · 1 location(s) · LaNova Medicines Limited · NCT07362186A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophagea
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06506292Screening for Early Gastric Cancer in Shaanxi Province
Phase N/A · 1 location(s) · Second Affiliated Hospital of Xi'an Jiaotong University · NCT05291728Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer
Phase 2 · 3 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07689851
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.